51
Choi Hoo Kyun: Transdermal drug delivery system containing granisetron. Echo Pacific, Choi Hoo Kyun, LEE Byung Hyun, July 16, 2009: WO/2009/088142 (2 worldwide citation)

Disclosed herein is a transdermal system in a matrix form capable of enhancing granisetron carrying efficiency and improving transdermal absorption while inhibiting recrystallization, which comprises: at least one transdermal enhancer selected from a group consisting of polyglyceryl-3 oleate, polyet ...


52

53
Campbell Patricia S, Eckenhoff James B, Place Virgil A: Transdermal system ii.. Alza, August 19, 1987: EP0232580-A2 (1 worldwide citation)

A transdermal therapeutic system is provided which is adapted for delivery of a biologically active agent over an extended time period said system comprising a matrix containing an agent disposed therein, the intended body distal surface of said matric having fibrous reinforcing means embedded there ...


54
Fischer Wilfried Dr, Piecha Thomas Dr: Transdermal systems for the release of muscarinic receptor antagonists and use thereof for treatement of smooth muscle spasms in urology. Novosis Pharma, January 31, 2001: EP1072260-A1 (1 worldwide citation)

A transdermal system for the release of muscarinic receptor antagonists comprises the active compound, tea tree oil and a water-miscible solvent. A transdermal system for the release of muscarinic receptor antagonists comprises the active compound, tea tree oil and a water-miscible solvent.


55

56
Landrau Felix A, Nedberge Diane E, Hearney Linda M: Incorporating poly-n-vinyl amide in a transdermal system. Alza, April 10, 1996: EP0705097-A1 (1 worldwide citation)

PCT No. PCT/US94/07267 Sec. 371 Date Dec. 14, 1995 Sec. 102(e) Date Dec. 14, 1995 PCT Filed Jun. 24, 1994 PCT Pub. No. WO95/01167 PCT Pub. Date Jan. 12, 1995The present invention comprises a composition comprising a matrix adapted to be placed in drug-and permeation-enhancing mixture-transmitting re ...


57
Strungmann Thomas: Systeme therapeutique transdermique pour administration de candesartan, Transdermal therapeutic system for the administration of candesartan. Hexal, Hexal, GOUDREAU GAGE DUBUC, November 11, 1999: CA2331414 (1 worldwide citation)

The invention relates to a transdermal system containing an active ingredient and used for the administration of candesartan or its pharmaceutically compatible esters and salts.


58
Mutzbauer Till S: (De) Transdermal applizierbares beruhigungs- und sedierungsmittel, (En) Transdermally administerable tranquilizing and sedating agent. Mutzbauer Till S, MUTZBAUER Helmut, October 28, 2004: WO/2004/091589 (1 worldwide citation)

(EN) An externally administerable agent, particularly a transdermal system for treating states of agitation or for use in preoperative sedation, contains, in an adhesive dressing preparation, a pharmaceutically effective amount of propofol (2,6-diisopropyl phenol) or of benzodiazepine or of another ...


59
Levin Galit, Sacks Hagit: Transdermal system for sustained delivery of polypeptides. Transpharma Medical, Levin Galit, Sacks Hagit, WEBB Cynthia, June 23, 2005: WO/2005/056075 (1 worldwide citation)

The present invention relates to a transdermal system for sustained delivery of high molecular weight hydrophilic drugs, especially peptide-, polypeptide- or protein-drugs and to methods of use thereof. The system comprises an apparatus that generates micro-channels in the skin of a subject in conju ...


60
Tamada Janet: Device and method for sampling of substances using alternating polarity. Cygnus, sSHAY James R, January 4, 1996: WO/1996/000109 (1 worldwide citation)

A method for sampling of a substance from a subject is provided, which comprises placing one or more sampling chambers on a collection site on a tissue surface on the subject; conducting electric current through the tissue to extract a substance from the subject in a first direction in one or more s ...